Internal Medicine, Hematology & Oncology · Newnan, GA
NPI
1699094300
Since 2010
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
775 Poplar Rd Ste 310
Newnan, GA, 30265
Phone (770) 251-2590
Groups this clinician bills Medicare through
Medicare paid, 2024
$6.1M
309,686 services
Medicare patients, 2024
675
Average age 75
Drug cost, 2024
$10.5M
5,126 prescriptions
Company payments, 2025
$479
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Minesh D Patel was code J0881 (injection, darbepoetin alfa, 1 microgram (non-esrd use)), 38,500 times for 16 patients. In total Minesh D Patel billed 309,686 services in 138 codes, and Medicare paid $6.1M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-05-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 38,500 | 16 | $2.21 | $85K |
| J1442 Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram | Office | 30,480 | 14 | $0.73 | $22K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 30,400 | 30 | $42.47 | $1.3M |
| J0897 Injection, denosumab, 1 mg | Office | 11,760 | 40 | $19.58 | $230K |
| J9267 Injection, paclitaxel, 1 mg | Office | 11,532 | 15 | $0.08 | $902 |
| Q5123 Injection, rituximab-arrx, biosimilar, (riabni), 10 mg | Office | 4,585 | 13 | $30.34 | $139K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 4,500 | 36 | $14.67 | $66K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,909 | 64 | $0.09 | $249 |
| 85025 Blood Count | Office | 1,460 | 527 | $7.56 | $11K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,160 | 27 | $0.67 | $780 |
| 99213 Office E&M - Established | Office | 818 | 413 | $57.28 | $47K |
| 96413 Chemotherapy Administration | Office | 725 | 116 | $82.65 | $60K |
| 96372 Injection Administration | Office | 683 | 127 | $9.25 | $6,319 |
| J9190 Injection, fluorouracil, 500 mg | Office | 674 | 12 | $2.19 | $1,474 |
| Q5111 Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg | Office | 432 | 11 | $97.29 | $42K |
By year: 2022 $5.0M for 272,685 services; 2023 $4.8M for 283,464 services; 2024 $6.1M for 309,686 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,460 | 527 | $7.56 | $11K |
| 81002 Clinical Chemistry | 98 | 64 | $3.41 | $334 |
Medicare prescription drug claims, 2024
In 2024, the drug Minesh D Patel prescribed most often to Medicare patients was Oxycodone Hcl, with 214 prescriptions and refills. In total Minesh D Patel wrote 5,126 Medicare prescriptions that cost $10.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone Hcl Generic | 214 | 216 | 57 | $4,931 |
| Valacyclovir Valacyclovir Hcl | 210 | 375 | 57 | $8,449 |
| Anastrozole Generic | 207 | 452 | 66 | $2,756 |
| Revlimid Lenalidomide | 191 | 191 | 24 | $2.7M |
| Eliquis Apixaban | 187 | 300 | 55 | $173K |
| Prednisone Generic | 182 | 230 | 83 | $593 |
| Ondansetron Odt Ondansetron | 147 | 150 | 107 | $2,670 |
| Dexamethasone Generic | 145 | 170 | 84 | $3,284 |
| Pantoprazole Sodium Generic | 138 | 320 | 73 | $1,702 |
| Abiraterone Acetate Generic | 128 | 128 | 18 | $316K |
| Tramadol Hcl Generic | 101 | 101 | 40 | $1,264 |
| Prochlorperazine Maleate Generic | 100 | 106 | 76 | $1,782 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 99 | 99 | 29 | $2,584 |
| Famotidine Generic | 98 | 163 | 42 | $833 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 90 | 91 | 66 | $1,078 |
Brand drugs: - claims; generic drugs: 3,858 claims; opioid claims: 605.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Minesh D Patel $479 ($479 in general payments such as food, travel and fees) from 13 companies. The largest payer was Abbvie Inc. with $127.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 6 | $127 |
| Taiho Oncology, Inc. 4578.T | 2 | $69.46 |
| Pfizer Inc. PFE | 3 | $63.73 |
| Daiichi Sankyo Inc. 4568.T | 1 | $29.72 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $26.16 |
| BeOne Medicines USA, Inc. ONC | 1 | $25.37 |
| Genzyme Corporation SNY | 1 | $24.29 |
| CSL Behring CSL.AX | 1 | $23.67 |
| Genentech USA, Inc. ROG.SW | 1 | $21.87 |
| SpringWorks Therapeutics, Inc. | 1 | $18.54 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.